Your browser doesn't support javascript.
loading
Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.
Shi, Wenyin; Blomain, Erik S; Siglin, Joshua; Palmer, Joshua D; Dan, Tu; Wang, Yang; Werner-Wasik, Maria; Glass, Jon; Kim, Lyndon; Bar Ad, Voichita; Bhamidipati, Deepak; Evans, James J; Judy, Kevin; Farrell, Christopher J; Andrews, David W.
Afiliación
  • Shi W; Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA. Wenyin.Shi@jefferson.edu.
  • Blomain ES; Jefferson College of Population Health, Thomas Jefferson University, Philadelphia, PA, USA.
  • Siglin J; Department of Radiation Oncology, University of Pittsburgh Medical Center, Altoona Cancer Center, Altoona, PA, USA.
  • Palmer JD; Department of Radiation Oncology, Ohio State University, Columbus, OH, USA.
  • Dan T; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
  • Wang Y; Cyberknife Center, Huashan Hospital Pudong, Fudan University, Shanghai, China.
  • Werner-Wasik M; Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
  • Glass J; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Kim L; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Bar Ad V; Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
  • Bhamidipati D; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
  • Evans JJ; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Judy K; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Farrell CJ; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Andrews DW; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
J Neurooncol ; 137(1): 171-177, 2018 Mar.
Article en En | MEDLINE | ID: mdl-29235052
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Encefálicas / Terapia Recuperativa / Fraccionamiento de la Dosis de Radiación / Bevacizumab / Antineoplásicos Inmunológicos / Glioma / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Encefálicas / Terapia Recuperativa / Fraccionamiento de la Dosis de Radiación / Bevacizumab / Antineoplásicos Inmunológicos / Glioma / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos